Therapeutic Equivalence of an Omalizumab Biosimilar (ADL-018) to European Union-approved reference Omalizumab (EU-OMA) in Chronic Spontaneous Urticaria

AVT23 (omalizumab biosimilar) - Kashiv Biosci, Alvotech, Advanz Pharma, MS Pharma, Cristalia, Amneal

https://academic.oup.com/bjd/issue/195/Supplement_1

Marta Delgado 1; Agustin Rivas 2; Krina Patel 3; Prayag Shah 4; Pawan Singh 5; Komal Vadday 6

Jun 30, 2026